Back

Mediation role of mean blood pressure in the relationship between the changes of TyG-WHtR and incident MACE

30 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (2) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Xingyu Luo

Peking University First Hospital, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Is lipoprotein(a) a stable measurement over time?
Doctor G. Cortez Quiroga (Andújar, ES)
Abstract Slides Video
Presentation thumbnail
Are conventional cardiovascular risk scoring models predictive of coronary plaque progression?
Doctor C. Soh (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Ethnic differences in lipoprotein(a)-associated ASCVD risk and the impact of standard modifiable cardiovascular risk factors: insights from the multi-ethnic HELIUS cohort
Doctor M. Annink (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Performance of the PREVENT risk score for atherosclerotic cardiovascular disease in a diverse population-based cohort study: comparative assessment against the recalibrated WHO CVD risk score
Doctor A. Pedroso (New Haven, US)
Abstract Slides Video
Presentation thumbnail
Identification of different lipid profiles in patients with zero calcium score with or without plaques after coronary computed tomography: a prospective registry to refine primary prevention
Mrs S. Alsubai (Galway, IE)
Abstract Slides

Access the full session

Session thumbnail
Risk factors (2)

The Event

Event poster

ESC Congress 2025

30 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of triglyceride-glucose index and vascular aging with cardiovascular diseases in China: PURE cohort study
thumbnail
Congress Presentation
Associations of TyG Index and TyG-obesity-related parameters to cardiovascular disease
thumbnail
Congress Presentation
The triglyceride-glucose index is a predictor for cardiovascular events and all-cause mortality in young and middle-aged patients with metabolic syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources